Pharmacological characterization of α2D-adrenergic receptor-mediated [35S]GTPγS binding in rat cerebral cortical membranes

Pharmacological Research

Volumn 57, Issue 6, 2008, Pages 435-444

  Odagaki, Yuji ^a   Toyoshima, Ryoichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

2 Adrenergic receptor; 35S GTP S binding; Epinephrine; G protein; UK 14,304

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; AGMATINE; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA 2D ADRENERGIC RECEPTOR; APRACLONIDINE; AZEPEXOLE; BENOXATHIAN; BRIMONIDINE; CLONIDINE; GUANFACINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; IMILOXAN; MAGNESIUM CHLORIDE; NORADRENALIN; OXYMETAZOLINE; RAUWOLSCINE; SEROTONIN 1A RECEPTOR; SODIUM CHLORIDE; SULFUR 35; TALIPEXOLE; TECIPTILINE; UNINDEXED DRUG; XYLAZINE; YOHIMBINE; ADRENERGIC RECEPTOR ALPHA(2D); ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CATION; LIGAND;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MEMBRANE; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; ISOTOPE LABELING; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; ANIMAL; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; MEMBRANE; METABOLISM; SPRAGUE DAWLEY RAT; STATISTICAL ANALYSIS; TISSUE PRESERVATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CATIONS; CEREBRAL CORTEX; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; LIGANDS; MAGNESIUM CHLORIDE; MALE; MEMBRANES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-2; SODIUM CHLORIDE; TISSUE PRESERVATION; YOHIMBINE;

EID: 47049117821     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.04.006     Document Type: Article

References (41)

1. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., et al. International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46 (1994) 121-136
2. Hieble J.P., Bondinell W.E., and Ruffolo Jr. R.R. α- and β-Adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. J Med Chem 38 (1995) 3415-3444
3. 2-adrenoceptor subtypes. Ann Rev Pharmacol Toxicol 32 (1993) 243-279
4. Ruffolo Jr. R.R., Bondinell W., and Hieble J.P. α- and β-Adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J Med Chem 38 (1995) 3681-3716
5. 2-adrenoceptor signal transduction: receptor subtypes, coupling to distinct signal transduction pathways and localization to discrete subdomains in target cells. Pharmacol Commun 6 (1995) 139-145
6. 35S]GTPγS binding assay: approaches and applications in pharmacology. Life Sci 74 (2003) 489-508 10.1016/j.lfs.2003.07.005
7. 35S]GTPγS binding to guanine-nucleotide-binding-proteins in human platelet membranes. Life Sci 64 (1999) 1403-1413
8. Bylund D.B., Ray-Prenger C., and Murphy T.J. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245 (1988) 600-607
9. 2-Adrenoceptor-stimulated GTPγS binding in rat brain: an autoradiographic study. Eur J Pharmacol 399 (2000) 17-27
10. 2 adrenoceptor-mediated G-protein activation in amygdale and lateral septum. Neuropharmacology 39 (2000) 1111-1113
11. Happe H.K., Bylund D.B., and Murrin L.C. Alpha-2 adrenergic receptor functional coupling to G proteins in rat brain during postnatal development. J Pharmacol Exp Ther 288 (1999) 1134-1142
12. 35S]GTPγS binding in rat cerebral cortex. Eur J Pharmacol 521 (2005) 49-58 10.1016/j.ejphar.2005.07.018
13. b from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Trends Pharmacol Sci 14 (1993) 237-239
14. 1-adrenoreceptors. J Med Chem 27 (1984) 1535-1536
15. 2B-adrenoceptor subtypes. Eur J Pharmacol 168 (1989) 381-386
16. 2B-adrenoceptor antagonist. Br J Pharmacol 99 (1990) 560-564
17. 2-adrenoceptors: implications for receptor classification. Br J Pharmacol 106 (1992) 1011-1018
18. Hudson A.L., Gough R., Tyacke R., Lione L., Lalies M., Lewis J., et al. Novel selective compounds for the investigation of imidazoline receptors. Ann N Y Acad Sci 881 (1999) 81-91
19. 2-adrenoceptor. Br J Pharmacol 106 (1992) 986-995
20. 1A receptors in human frontal cortex membranes. Eur J Pharmacol 207 (1991) 1-8
21. Winter J.C., and Rabin R.A. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 263 (1992) 682-689
22. 1A receptors. Biochem Pharmacol 45 (1993) 2337-2341
23. 35S]GTPγS binding to cortical membranes from postmortem human brain. Eur J Pharmacol 390 (2000) 25-36
24. Gilman A.G. G proteins: transducers of receptor-generated signals. Ann Rev Biochem 56 (1987) 615-649
25. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol Pharmacol 45 (1994) 524-531
26. 2-adrenergic receptors by sodium. J Biol Chem 265 (1990) 21590-21595
27. 3H]UK-14,304 and inhibition of adenylate cyclase. Mol Pharmacol 28 (1985) 422-430
28. 35S]GTPγS binding. Biochem Pharmacol 55 (1998) 1035-1043
29. 2A-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes. Br J Pharmacol 129 (2000) 1333-1338
30. Hoyer D., and Boddeke H.W.G.M. Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol Sci 14 (1993) 270-275
31. Kenakin T. Efficacy in drug receptor theory: outdated concept or under-valued tool?. Trends Pharmacol Sci 20 (1999) 400-405
32. Kenakin T. Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 1 (2002) 103-110
33. Lefkowitz R.J. Seven transmembrane receptors: something old, something new. Acta Physiol 190 (2007) 9-19
34. 2-adrenoceptors. Eur J Pharmacol 355 (1998) 275-279
35. B, and pirenzepine-insensitive muscarinic receptors are functionally coupled to distinct pools of the same kind of G proteins in rat hippocampus. Brain Res 689 (1995) 129-135
36. Odagaki Y., Dasgupta S., and Fuxe K. Additivity and non-additivity between dopamine-, norepinephrine-, carbachol- and GABA-stimulated GTPase activity. Eur J Pharmacol 291 (1995) 245-253
37. Feuerstein T.J., Hertting G., and Jackisch R. Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynathine as α-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol 329 (1985) 216-221
38. 2-adrenergic receptor mRNAs in the rat CNS. Mol Brain Res 10 (1991) 219-225
39. 2-adrenergic receptor subtype gene expression in rat brain. Mol Brain Res 21 (1994) 133-149
40. 3H]MK912 and subtype-selective drugs. Brain Res 770 (1997) 261-266
41. Ordway G.A., Jaconetta S.M., and Halaris A.E. Characterization of subtypes of alpha-2 adrenoceptors in the human brain. J Pharmacol Exp Ther 264 (1993) 967-976